Generated: December 11, 2017
DrugPatentWatch Database Preview
Details for Patent: 8,733,341
« Back to Dashboard
Which drugs does patent 8,733,341 protect, and when does it expire?
Summary for Patent: 8,733,341
|Title:||Atomizer and method of atomizing fluid with a nozzle rinsing mechanism|
|Abstract:|| An atomizer and a method of dispensing and atomizing fluid into individual containers through a nozzle are proposed, where in order to improve the dosing accuracy, a preliminary amount of fluid, flushing the nozzle, is dispensed before each dose is dispensed.|
|Inventor(s):|| Boeck; Georg (Laupheim, DE), Spallek; Michael (Ingelheim, DE) |
|Assignee:|| Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
Patent Claim Types:|
see list of patent claims
|Delivery; Device; Formulation; Use; |
||Patented / Exclusive Use
|Boehringer Ingelheim||COMBIVENT RESPIMAT||albuterol sulfate; ipratropium bromide||SPRAY, METERED;INHALATION||021747-001||Oct 7, 2011||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||STIOLTO RESPIMAT||olodaterol hydrochloride; tiotropium bromide||SPRAY, METERED;INHALATION||206756-001||May 21, 2015||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||STRIVERDI RESPIMAT||olodaterol hydrochloride||SPRAY, METERED;INHALATION||203108-001||Jul 31, 2014||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||SPIRIVA RESPIMAT||tiotropium bromide||SPRAY, METERED;INHALATION||021936-002||Sep 15, 2015||RX||Yes||No||► Subscribe||► Subscribe||► Subscribe||Y|
|Boehringer Ingelheim||SPIRIVA RESPIMAT||tiotropium bromide||SPRAY, METERED;INHALATION||021936-001||Sep 24, 2014||RX||Yes||Yes||► Subscribe||► Subscribe||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Foreign Priority and PCT Information for Patent: 8,733,341
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|Germany||10 2006 022 002||May 10, 2006|
|PCT Filed||April 16, 2007||PCT Application Number:||PCT/EP2007/003322|
|PCT Publication Date:||November 15, 2007||PCT Publication Number:||
International Patent Family for Patent: 8,733,341
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.